As of 2024-12-15, the Fair Value of Bioventus Inc (BVS) is -2.43 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 11.03 USD, the upside of Bioventus Inc is -122.05%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | 6.90 | 16.40 | 19.40 | -158.70 | -156.23 | -54.45 |
| YoY growth | 156.56% | 137.68% | 18.29% | -918.04% | 1.56% | -120.79% |
| Market Cap (mil) | 895.08 |
| P/E | |
| Forward P/E |
| EPS | -0.49 |
| Avg earnings growth rate | -120.79% |
| TTM earnings | -39.48 |